Passionate about returning Big Pharma's power to the people, Marc DeValera, founder of MLFD-MedTech Inc., developed 3 ...

According to Research by SNS Insider, Nebulizer Market Growth is Driven by Rising Prevalence of Chronic Respiratory Diseases and Technological Advancements.Austin, Oct. 18, 2024 (GLOBE NEWSWIRE) -- ...

Dr Shiv Tej N and Dr Venugopal Reddy I, members of the Pediatric Team at Ovum Woman and Child Hospital, Bangalore, explain ...

The Asthma Society of Ireland has warned that over-use of steroid medication may cause more harm than good. A study has shown ...

UK-based pharmaceutical company AstraZeneca has reported that its Phase IIIb BATURA trial of Airsupra (albuterol/budesonide) ...

The increasing demand for asthma treatment is largely driven by the rising number of asthma cases. Factors such as increased smoking and air pollution are impairing lung function and contributing to ...

Depemokimab has already shown its potential as a therapy for severe asthma in two other phase 3 trials – SWIFT-1 and SWIFT-2 ...

An asthma attack always requires prompt treatment to prevent life-threatening complications. Treatment varies from person to person but typically includes medications that reduce airway ...

In another Gazzette notification, the drug pricing regulator fixed the retail price of 20 new drugs under the provisions of ...

Asthma affects about seven million children in the U.S. But kids who have asthma can lead normal, active lives with the right ...

A study showing women with asthma are more likely to miscarry and have fertility problems 'highlights the need for good ...

The global asthma treatment market size was valued at USD 27.51 billion in 2023 and is expected to reach around USD 35.93 billion by 2034. It is growing at a CAGR of 2.42% from 2024 and 2034. The ...